Tagged with ARM

Eurofarma Eurofarma entered the Peruvian market in 2013 through the acquisition of local player Refasa-Carrión. Rómulo García, the affiliate’s ambitious general manager, discusses the merge and his quest to become a top ten player in the market. Can you give us a brief introduction to Eurofarma; starting from your foundation to…

medical devices Philips aims at becoming the leading provider of solutions across the full ‘continuum of care’. The general manager of the healthcare division in Mexico explains how the company has made customer service, education, software and integrated solutions the strategic pillars to find innovative ways to deliver healthcare. What are the…

pharmacies The founder of the group explains how the pharmacy chain has become a regional trailblazer by redefining the concept of ‘neighborhood pharmacy’ along the principles of being cheap, near and well-stocked. What was your vision behind starting Ecofarmacia? I am a medically trained doctor and I started off my career…

generics At Valeant each region has a unique mix of prescription brands, branded generics and OTC products. The general manager for Mexico, Central America, the Caribbean and the Andean region discusses the company’s objectives for Spanish speaking Latin America and how it plans to leverage the recently acquired Bausch+Lomb business to…

Mexico At Leo Pharma it’s not just about skin conditions. It’s about the people living with them. The recently appointed senior director for Latin America discusses the plans of the company for the region and how, in collaboration with dermatologists, it aims at reaching out to an increasing number of patients.…

Yungjin The CEO of Yungjin, a leading Korean pharma company, talks about the revitalization of the company he has overseen since being appointed in 2010.   To begin, could you please introduce yourself, and Yungjin? Yungjin has a long history; it is one of the oldest pharmaceutical companies in Korea, having…

Ferring The country manager of a research-driven, specialty biopharmaceutical group offering treatments for infertility outlines his firm’s approach for the socially conservative Algerian market. Your promotion as general manager of Ferring Algeria is quite recent. Can you tell us what were your priorities during the first year and how do you…

reimbursement The country manager of a JNJ affiliated company advocates deploying electronic healthcare techniques to transform the reach of local practitioners and speaks out about the sort of local adaptations that need to be considered when introducing new products to the Algerian market. What is your evaluation of the Algerian pharmaceutical…

R&D Lee Kyoung-Ryul has served as Chairman of SCL Healthcare Group since 2007. He discusses the diagnostic service providers’ extensive network in Korea as well as their ambitious plans to export their systems to China. What has been the most important long-term goal for you since you started? The most important…

biotech On February second, the Korean Ministry of Health and Welfare announced the start of a second round of financing to the biopharmaceutical industry, as part of the Global Pharmaceutical Industry Development Fund (GPIDF). A total of USD 123 million will be invested in Korean pharmaceutical and biotech companies for the…

pharmaceuticals With a wealth of experience in different countries around the world, Christophe Piganiol came to Korea as general manager of Zuellig Pharma in 2010. Today he discusses the importance of transparency in a volatile market and the introduction of new business models to satisfy customer demand. What were your impressions…

healthcare The co-president of a research group dedicated to Euro-Mediterranean health sector issues analyses commonalities across the North African region and calls for a coordinated response to shared challenges. He also delivers a comparative assessment of the Algerian market. What is your opinion about the evolution of the Algerian pharmaceutical industry and…